Vincerx Pharma, Inc. (VINC) earnings
VINC earnings moved a median of -2.87% by the close. Quarterly and annual VINC reports and results, each read against the price at its own news timestamp. Back to the VINC overview →
11 measured VINC earnings events.
Where these VINC earnings landedvs 11 measured VINC earnings reactions
| Middle 50% of VINC earnings reactions | -6.89% to -1.91% |
|---|---|
| Median reaction (to close) | -2.87% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 VINC earnings events with a measured close landed between -6.89% and -1.91%; 18% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Vincerx Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +10.00% | |
| Form 10-K Vincerx Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.11% | -1.91% | |
| Form 10-Q Vincerx Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.16% | -1.91% | |
| Vincerx Pharma Reports Third Quarter 2024 Financial Results | Press release | +0.61% | -1.91% | |
| Form 10-Q Vincerx Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.99% | -13.74% | |
| Vincerx Pharma Reports Second Quarter 2024 Financial Results | Press release | -0.99% | -13.74% | |
| Form 10-Q Vincerx Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.10% | -2.87% | |
| Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +1.10% | -2.87% | |
| Form 10-K Vincerx Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.23% | +19.63% | |
| Form 10-Q Vincerx Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -6.89% | |
| Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | — | -6.89% |
Keep exploring
More VINC: analyst actions → · SEC filings → · VINC overview →